Posted by John Murawski on November 21, 2014
Burlington-based Laboratory Corporation of America said Friday it has completed its $85.3 million acquisition of LipoScience, a Raleigh company whose diagnostics tool measures heart disease risk.
LabCorp said LipoScience shareholders approved the acquisition Thursday at a special meeting. The shareholder approval closed the transaction and ceased the trading of LipoScience public shares.
LipoScience went public in 2013 and quickly ran into trouble. Earlier this year the company laid off 22 employees and ended a contract with Health Diagnostic Laboratory, after the Richmond-based company put out a product to compete with LipoScience.
Posted by David Ranii on November 20, 2014
The workers' compensation rates paid by most North Carolina employers will decline an average of 3.4 percent next year. The 3.4 percent decrease is an average and will impact about 95 percent of employers, according to Insurance Department spokeswoman Kerry Wall. Rates will vary significantly based on an employers' claims experience and the types of workers employed.
Posted by John Murawski on November 20, 2014
Chapel Hill drug developer Cempra has been awarded a federal grant of $16 million as part of a five-year $58.6 million research contract with the Biomedical Advanced Research and Development Authority, or BARDA.
Posted by David Ranii on November 19, 2014
Raleigh-based PRA Health Sciences, which went public last week, announced that its underwriters have exercised their option to purchase an additional 2.5 million shares at the initial public offering price.